A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

NCT03124498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: CIK Cell

Sponsor

Chuan An Biotechnology Co., Ltd.